ArticleBritish journal of cancer2018

Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers.

Shiraj Sen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.